• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcus Biosciences, Inc. Common Stock (NY: RCUS )

15.50 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 15.50
Bid (Size) 6.240 (1)
Ask (Size) 20.00 (1)
Prev. Close 15.50
Today's Range 15.50 - 15.50
52wk Range 13.52 - 20.31
Shares Outstanding 91,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
December 10, 2024
From Arcus Biosciences
Via Business Wire

Performance

YTD
-21.24%
-21.24%
1 Month
+5.44%
+5.44%
3 Month
-1.34%
-1.34%
6 Month
-5.55%
-5.55%
1 Year
-15.85%
-15.85%

More News

Read More
Arcus Biosciences Announces New Employment Inducement Grants
December 03, 2024
From Arcus Biosciences
Via Business Wire
Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts
November 06, 2024
Via Benzinga
Unveiling 5 Analyst Insights On Arcus Biosciences
October 21, 2024
Via Benzinga
Where Arcus Biosciences Stands With Analysts
October 21, 2024
Via Benzinga
Demystifying Arcus Biosciences: Insights From 4 Analyst Reviews
October 03, 2024
Via Benzinga
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
November 19, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 12, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
November 06, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer
November 05, 2024
From Arcus Biosciences
Via Business Wire
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
August 09, 2024
Via Benzinga
Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting
October 30, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 24, 2024
From Arcus Biosciences
Via Business Wire
First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer
October 24, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update
October 22, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 09, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
October 09, 2024
From Arcus Biosciences
Via Business Wire
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 08, 2024
Via Benzinga
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
October 02, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 24, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 10, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
August 27, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 26, 2024
From Arcus Biosciences
Via Business Wire
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
August 21, 2024
From Arcus Biosciences
Via Business Wire
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap